United Therapeutics Corp. (UTHR)
562.02
-3.70
(-0.65%)
USD |
NASDAQ |
Nov 06, 16:00
566.66
+4.64
(+0.83%)
After-Hours: 20:00
United Therapeutics Total Long Term Debt (Quarterly) : 0.00 for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.00 |
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 200.00M |
| December 31, 2024 | 300.00M |
| September 30, 2024 | 400.00M |
| June 30, 2024 | 500.00M |
| March 31, 2024 | 600.00M |
| December 31, 2023 | 700.00M |
| September 30, 2023 | 800.00M |
| June 30, 2023 | 800.00M |
| March 31, 2023 | 800.00M |
| December 31, 2022 | 800.00M |
| September 30, 2022 | 800.00M |
| June 30, 2022 | 800.00M |
| March 31, 2022 | 800.00M |
| December 31, 2021 | 800.00M |
| September 30, 2021 | 800.00M |
| June 30, 2021 | 800.00M |
| March 31, 2021 | 800.00M |
| December 31, 2020 | 800.00M |
| September 30, 2020 | 800.00M |
| Date | Value |
|---|---|
| June 30, 2020 | 800.00M |
| March 31, 2020 | 800.00M |
| December 31, 2019 | 853.00M |
| September 30, 2019 | 1.003B |
| June 30, 2019 | 1.054B |
| March 31, 2019 | 1.054B |
| December 31, 2018 | 250.00M |
| September 30, 2018 | 250.00M |
| June 30, 2018 | 250.00M |
| March 31, 2018 | 250.00M |
| December 31, 2017 | 250.00M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.90M |
| March 31, 2016 | 5.40M |
| December 31, 2015 | 5.387M |
| September 30, 2015 | 30.02M |
| June 30, 2015 | 32.28M |
| March 31, 2015 | 115.22M |
| December 31, 2014 | 126.48M |
| September 30, 2014 | 291.32M |
| June 30, 2014 | 363.33M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Liquidia Corp. | 182.90M |
| Alnylam Pharmaceuticals, Inc. | 2.951B |
| Exelixis, Inc. | 162.20M |
| Gilead Sciences, Inc. | 26.23B |
| Insmed, Inc. | 741.61M |